닫다
- Patent
- 특허 솔루션
- Trademark
- 상표 솔루션
- 혁신
- 혁신 솔루션
- 솔루션
- 솔루션
- Contact
더
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- Best-in-class Customer ExperienceOur goal is to exceed our clients' expectations and share best practices
- IP TrainingIncrease the IP-IQ of your entire organization with engaging IP training programs/ip-training-for-non-specialists/
- Resource Hub
- About Questel
- Learn & Support
- Learn and support
- Resource HubAccess value added content to support your IP strategy
- Webinars & EventsAre you interested in attending one of our online or onsite event?
- Product TrainingsCustomer success is our priority. Increase your skills in the use of Questel’s software
- Product NewsA platform dedicated to software and platforms news and evolutions
- Best-in-class Customer ExperienceOur goal is to exceed our clients' expectations and share best practices
- IP TrainingIncrease the IP-IQ of your entire organization with engaging IP training programs/ip-training-for-non-specialists/
- Resource Hub
- About Questel
KO
웨비나 / 게시됨, 2019년 11월 19일
CRISPR 기반 도구를 사용할 권리가 있습니까 - Genoway, Merck 및 Questel과의 공동 비디오
overview
CRISPR를 포함한 1200개 이상의 특허군을 보유하고 있는데, 이 기술을 사용할 때 제3자의 권리를 침해하는지 여부를 실제로 알고 계십니까?
4명의 업계 전문가가 이 웨비나에서 다음 주제에 대한 의미 있는 통찰력과 피드백을 제공합니다.
- 모델 생성을 위한 CRISPR 사용(Amélie Rezza, genOway)
- CRISPR 특허 환경 개요(Mathieu Fontaine, Questel)
- 특정 Merck CRISPR 지원 프로세스 범위(Ajay Rastogi, Merck)
- CRISPR/Cas9 기반 도구를 자유롭게 사용할 수 있습니다(Sandrine Carteau, genOway)
동영상 보다